This product is for research use only, not for human use. We do not sell to patients.
| Size | Price | Stock |
|---|---|---|
| 5mg | $50 | 3-6 Days |
| 10mg | $80 | 3-6 Days |
| 25mg | $150 | 3-6 Days |
| 50mg | $200 | 3-6 Days |
| 100mg | $350 | 3-6 Days |
| 250mg | $550 | 3-6 Days |
| 500mg | $900 | 3-6 Days |
| 1g | $1550 | 3-6 Days |
: Cat #: V6429 CAS #: 1259305-29-7 Purity ≥ 98%
Description: Aripiprazole lauroxil (RDC3317; RDC-3317; ALKS 9070; ALKS-9072; Abilify; Aristada) is a long-acting injectable atypical antipsychotic approved in 2015 by FDA mainly for the treatment of schizophrenia and bipolar disorder. It can also be used as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism. Aripiprazole lauroxil is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
| Molecular Weight (MW) | 660.721 |
|---|---|
| Molecular Formula | C36H51Cl2N3O4 |
| CAS No. | 1259305-29-7 |
| Synonyms | RDC 3317; ALKS 9070; RDC-3317; RDC3317; ALKS 9072; Aripiprazole lauroxil; Aristada. |
| Solvent volume to be added | Mass (the weight of a compound) | |||
|---|---|---|---|---|
| Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
| 1mM | 1.5135 mL | 7.5675 mL | 15.1350 mL | 30.2700 mL |
| 5mM | 0.3027 mL | 1.5135 mL | 3.0270 mL | 6.0540 mL |
| 10mM | 0.1513 mL | 0.7567 mL | 1.5135 mL | 3.0270 mL |
| 20mM | 0.0757 mL | 0.3784 mL | 0.7567 mL | 1.5135 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.